Bio-Thera Inks EUR 136m Deal with STADA for BAT1806 Commercialization
On August 21, 2025, Bio-Thera Solutions, Ltd. (SHA: 688177) announced a license and commercialization agreement...
On August 21, 2025, Bio-Thera Solutions, Ltd. (SHA: 688177) announced a license and commercialization agreement...
Bain Capital is set to acquire Mitsubishi Tanabe Pharma Corporation (Tanabe Pharma) in a carve-out...
Germany-based Stada Arzneimittel AG has announced a strategic distribution and promotion partnership with China’s state-owned...